From April 1, 2022 to June 30, 2022, the company has repurchased 744,858 shares, representing 2.9% for $2.89 million. With this, the company has completed the repurchase of 2,675,872 shares, representing 10.03% for $11.44 million under the buyback announced on November 17, 2021.
La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |